TNFα dynamics during the oral glucose tolerance test vary according to the level of insulin resistance in pregnant women

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1862-1869

  Guillemette, Laetitia ^a   Lacroix, Marilyn ^a   Battista, Marie Claude ^a   Doyon, Myriam ^b   Moreau, Julie ^b   Ménard, Julie ^b   Ardilouze, Jean Luc ^a,b   Perron, Patrice ^a   Hivert, Marie France ^a,b,c,d  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FIRST TRIMESTER PREGNANCY; HOMEOSTASIS MODEL OF ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MATSUDA INDEX; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN FUNCTION; SECOND TRIMESTER PREGNANCY;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899974882     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4016     Document Type: Article

References (41)

1. CatalanoPM,Roman-DragoNM,Amini SB, Sims EA. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol. 1998;179(1):156-165.
2. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-is a predictor of insulin resistance in human pregnancy. Diabetes. 2002; 51(7):2207-2213.
3. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029-1033.
4. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365-371.
5. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91.
6. González F Minium J Rote NS Kirwan JP. Altered tumor necrosis factor-release fro m mononuclear cells of obese reproductive-age women during hyperglycemia Metabolism. 2006 55(2) 271-276.
7. Prins JB, Niesler CU, WinterfordCM,et al. Tumor necrosis factor-induces apoptosis of human adipose cells. Diabetes. 1997;46(12): 1939-1944.
8. Hotamisligil GS. The role ofTNF-andTNFreceptors in obesity and insulin resistance. J Intern Med. 1999;245(6):621-625.
9. Nieto-Vazquez I, Ferná ndez-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: The link TNF-. Arch Physiol Biochem. 2008;114(3):18 3-194.
10. Ruan H, Lodish HF. Insulin resistance in adipose tissue: Direct and indirect effects of tumor necrosis factor-. Cytokine Growth Factor Rev. 2003;14(5):447-455.
11. Altinova AE, Toruner F, Bozkurt N, et al. Circulating concentrations of adiponectin and tumor necrosis factor-in gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(3):161-165.
12. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor-mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139(2):327-335.
13. Haider S, Knöfler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111-123.
14. Asemi Z, Jazayeri S, Najafi M, et al. Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women. ARYA Atheroscler. 2013;9(3):172-178.
15. McIntyre HD, Chang AM, Callaway LK, et al. Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care. 2010;33(2):356-360.
16. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682.
17. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: Validation studies in women with normal glucose tolerance and gestational diabe tes mellitus. Diabetes Care. 2001;24(9):1602-1607.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
19. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470.
20. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring). 2008;16(8): 1901-1907.
21. Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med. 2009;26(12):1198-1203.
22. Lacroix M, Battista MC, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabete s mellitus. Diabetes Care. 2013;36(6):1577-1583.
23. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidat ive stress. Circulation. 2002;106(16):2067-2072.
24. Chu CS, Lee KT, Cheng KH, et al. Postchallenge responses of nitrotyrosine and TNF-during 75-g oral glucose tolerance test are associate d with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol. 2012;11:21.
25. Derosa G, Mereu R, D'Angelo A, et al. Effect of pioglitazone and acarbose on en dothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin. J Clin Pharm Ther. 2010;35(5):565-579.
26. McTernan PG, Harte AL, Ande rson LA, et al. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes. 2002;51(5):1493-1498.
27. Sewter CP Digby JE Blows F Prins J O'Rahilly S. Regulation of tumour necrosis factor-release from human adipose tissue in vitro J Endocrinol. 1999 163(1) 33-38.
28. Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Pedersen BK. Insulin stimulates interleukin-6 and tumor necrosis factor-gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab. 2004;286(2):E234- E238.
29. Donath MY, Stø rling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl). 2003;81(8):455-470.
30. Puder JJ, Varga S, Nusbaumer CP, et al. Women with polycystic ovary syndrome are sensitive to the TNF-lowering effect of glucose-induced hyperinsulinaemia. Eur J Clin Invest. 2006;36(12): 883-889.
31. d e Castro J, Sevillano J, Marciniak J, et al. Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy. Endocrinology. 2011;152(11):4094-4105.
32. Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM. Increased skeletal muscle tumor necrosis factor-and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes. 2008;57(3):606-613.
33. Jahromi AS, Zareian P, Madani A. Association of insulin resistance with serum interleukin-6 and TNF-levels during normal pregnancy. Biomark Insights. 2011;6:1-6.
34. Hivert MF, Sullivan LM, Shrader P, et al. The association of tumor necrosis factor-receptor 2 and tumor necrosis factor-with insulin resistance and the influence of adipose tissue bio markers in humans. Metabolism. 2010;59(4):540-546.
35. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE. Glucose-induced release of tumour necrosis factor-from human placental and a dipose tissues in gestational diabetes mellitus. Diabet Med. 2001;18(11):921-927.
36. Cseh K, Baranyi E, Melczer Z, et al. The pathophysiological influence of leptin and the tumor necrosis f actor system on maternal insulin resistance: negative correlation with anthropometric parameters of neonates in gestational diabetes. Gynecol Endocrinol. 2002; 16(6):453-460.
37. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8(7): 731-737.
38. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway. Circulation. 2000;102(11):1296-1301.
39. Lacroix M, Kina E, Hivert MF. Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep. 2013;13(2):238-244.
40. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes. 1997;46(3):451-455.
41. Cartier A, Cô téM, Bergeron J, et al. Plasma soluble tumour necrosis fact or-receptor 2 is elevated in obesity: specific contribution of visceral adiposity. Clin Endocrinol (Oxf). 2010;72(3):349-357.